Community Pharmacy England CEO Janet Morrison has given a video update on the Community Pharmacy Contractual Framework (CPCF) negotiations, addressing the prolonged pause that means the sector is still without an agreement for 2024/25. In her video message, Janet addresses the continued delay in recommencing negotiations, describing the “severe frustration and intense anger” that the Government
Read moreMHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) Drug alert number: EL (24)A/61 Date issued: 4 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) DMRC reference number:DMRC-34033472 Company
Read moreCommunity Pharmacy England has made a submission to the Government’s development of a 10-year Health Plan for the NHS, highlighting the benefits of increased commissioning of pharmacy services in tandem with addressing the sector’s current funding gap. In October, the Secretary of State for Health and Social Care launched a national conversation on the NHS, seeking
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (03/12/2024) announced the following final list of price concessions for November 2024: Please note these prices only apply to prescriptions submitted as dispensed in November 2024. Community Pharmacy
Read moreMHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) Drug alert number: EL (24)A/60 Date issued: 3 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) DMRC reference number: DMRC-31179592 Company name:
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo MSN/2024/111 Tier 2 – medium impact Date of issue: 3rd December 2024 Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo (all pack sizes) is being discontinued from February 2025 Alternative coal tar extract
Read moreCommunity Pharmacy England has released a set of resources to explain the introduction of Original Pack Dispensing (OPD), including how and when it will apply. From 1st January 2025, amendments made to the pharmacy regulations state that the supervising pharmacist must consider dispensing up to 10% more or less than the prescribed quantity, as appropriate,
Read moreMHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) Drug alert number: EL (24)A/59 Date issued: 2 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) DMRC reference number: DMRC-33616486 Company name:
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/11/2024) announced the following list of price concessions for November 2024: This is not the final update for November. We are still working with the DHSC to agree
Read moreIncreases to employers National Insurance contributions and the National Living Wage will cost community pharmacies £200 million a year in unplanned costs, national pharmacy bodies including Community Pharmacy England have warned today. They have told the Government that ‘without mitigation, these additional costs will push many pharmacies more towards insolvency’, leading even more to close
Read more
